FIELD: medicine.
SUBSTANCE: modified release pharmaceutical composition of antianginal actions characterised by the fact that it contains a therapeutically effective amount of trimethazidin, polymers and pharmaceutical aids, differing by the fact that polymers are Methocel K 100 MCR, Methocel K 15 MCR and microcrystalline cellulose in the following ratio, wt %: trimethazidin - 15.9; Methocel K 100 MCR - 15.0; Methocel K 15 MCR - 15.0; microcrystalline cellulose - 53.1; aerosyl - 0.5; stearate - 0.5.
EFFECT: simplified process of preparing modified drugs.
3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| MATRIX TABLET WITH BASIS FOR TRIMETAZIDINE DIHYDROCHLORIDE RELEASE, WAY OF ITS RECEPTION AND WAY OF TREATMENT | 2007 |
|
RU2362548C1 |
| PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
| PHARMACEUTICAL COMPOSITION WITH SUSTAINED-RELEASE OF GLICLAZIDE | 2004 |
|
RU2273482C2 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| TRIMETAZIDINE PREPARATION AS MATRIX TABLET OF PROLONGED ACTION AND METHOD FOR MAKING THEREOF | 2007 |
|
RU2377989C2 |
| PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| MATRIX TABLET WITH TRIMETAZIDINE PROLONGED-RELEASE BASE AND METHOD FOR PREPARING IT | 2010 |
|
RU2445958C2 |
